Anatomic Pathology Market Size, Share | 2022 - 2026

2021 – 2026
(Switzerland)
North America dominates the anatomic pathology market
The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine.
MARKET SEGMENTATION
THE MARKET WILL BE: KEY MARKET PLAYERS
MARKET OPPORTUNITY OVER NEXT 5 YEARS
35.1 Bn
49.1 Bn
billion by 2027
The report "Anatomic Pathology Market by Product & Service (Instruments (Cell Processor, Microtome), Consumable, Histopathology,
Cytopathology, Application (Disease Diagnosis (Cancer (Breast, Lung), End User (Hospital Laboratories), Region - Global Forecasts to
2026", is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. The growth of the anatomic pathology
market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of
reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected
to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period.
Browse 491 market data Tables and 45 Figures spread through 343 Pages and in-depth TOC on "Anatomic Pathology Market by
Product & Service (Instruments (Cell Processor, Microtome), Consumable, Histopathology, Cytopathology, Application (Disease
Diagnosis (Cancer (Breast, Lung), End User (Hospital Laboratories), Region - Global Forecasts to 2026"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html
billion by 2027
Anatomic Pathology Services segment accounted for the largest share of the global anatomic pathology market in 2020.
Based on product & service, the anatomic pathology market is segmented into services, consumables, and instruments. The services segment
accounted for the largest market share in 2020. The large share of this segment can be attributed to the availability of reimbursements for
diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.
By Application, disease diagnostics accounted for the largest market share in 2020
Based on application, the anatomic pathology market is segmented into disease diagnostics and medical research. The disease diagnostics
segment accounted for a larger share of the market in 2020 due to the rapid growth in the geriatric population and the increasing incidence of
cancer and other chronic diseases.
By End User, Hospital laboratories accounted for the largest market share in 2020
Based on end user, the anatomic pathology market is segmented into hospital laboratories, clinical laboratories, and other end users. Hospital
laboratories accounted for the largest share in 2020. The large share of this segment can be attributed to the increasing number of patient visits
to hospitals, the growing number of in-house diagnostic procedures performed in hospitals, growing awareness regarding early disease
diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.
Medical Device Reprocessing Market worth $3.9
billion by 2027
North America dominates the anatomic pathology market
The global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). In 2020,
North America accounted for the largest share of the anatomic pathology market. Factors such as the rising prevalence of chronic diseases,
increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players
in the region are driving the growth of the anatomic pathology market in North America.
The major players in the anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC Holdings
Corporation (Japan).
Don’t miss out on business opportunities in Anatomic Pathology Market. Speak to our analyst and gain crucial industry insights that
will help your business grow.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of
worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as
clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues
decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement
Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers,
write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies,
innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000
companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them
research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets
and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: